ArticleNeuropsychiatric disease and treatment2025
Psychometric Properties of the Chinese Version of the Anhedonia Scale for Adolescents and Identification of the Subpopulation with Prominent Anhedonia.
Article in Neuropsychiatric disease and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Assessing anhedonia in Chinese healthy and depressed adolescents: reliability, validity, and clinical utility of the anhedonia scale for adolescent.BMC psychiatry · 2026Article
- Sequential bilateral rTMS combined with fluoxetine for anhedonic depression in adolescents: clinical efficacy and peripheral inflammatory profiles.Frontiers in psychiatry · 2026Article
- The Importance of Measuring Social Anhedonia in Adolescence: A Case for the ACIPS-A [Letter].Neuropsychiatric disease and treatment · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Adolescent anhedonia (AA) exhibits distinct characteristics. Currently available anhedonia scales in Chinese are designed solely for adult populations. This investigation assessed the psychometric characteristics of the Chinese Anhedonia Scale for Adolescents (ASA-C) across clinical, subthreshold, and typically developing adolescent cohorts, while establishing its optimal cut-off for prominent anhedonia identification. The relationship between adverse childhood experiences (ACEs) and adolescent anhedonia was concurrently examined. Methods: Random allocation divided participants into exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) validation sets. While internal consistency was evaluated in all groups, other psychometric properties were examined exclusively in major depressive disorder (MDD) participants. Latent profile analysis (LPA) was conducted on the full sample to identify distinct subgroups. Receiver Operating Characteristic (ROC) analysis determined the optimal diagnostic threshold based on derived classifications. The Adverse Childhood Experiences International Questionnaire (ACE-IQ) quantified dimensional characteristics of childhood adversity. Results: Exploratory factor analysis (EFA) revealed a bifactor structure for the ASA-C (ie, positive and negative factors). Confirmatory factor analysis (CFA) demonstrated that this two-factor model exhibited satisfactory fit and achieved measurement invariance across all three groups. The scale displayed satisfactory internal consistency, test-retest reliability, convergent validity, discriminant validity, and concurrent validity. Latent profile analysis (LPA) classified the full sample into two distinct subgroups. A cut-off value of 20.5 was determined to be most effective for identifying marked anhedonia. Moreover, significant correlations were observed between adverse childhood experiences and total scores on the ASA-C. Conclusion: The ASA-C demonstrates robust reliability and validity for assessing anhedonia in Chinese adolescents, serving as a valuable tool for community screening, clinical assessment, and research applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.